Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing
Ho, H K, Németh, G, Ng, Y R, Pang, E, Szántai-Kis, C, Zsákai, L, Breza, N, Greff, Z, Horváth, Z, Pató, J, Szabadkai, I, Szokol, B, Baska, F, Őrfî, L, Ullrich, A, Kéri, G, Chua, B T
Published in Current medicinal chemistry (01.04.2013)
Published in Current medicinal chemistry (01.04.2013)
Get more information
Journal Article
Novel, selective CDK9 inhibitors for the treatment of HIV infection
Németh, G, Varga, Z, Greff, Z, Bencze, G, Sipos, A, Szántai-Kis, C, Baska, F, Gyuris, A, Kelemenics, K, Szathmáry, Z, Minárovits, J, Kéri, G, Orfi, L
Published in Current medicinal chemistry (2011)
Published in Current medicinal chemistry (2011)
Get more information
Journal Article
Pharmacophore and binding analysis of known and novel B-RAF kinase inhibitors
Baska, F, Szabadkai, I, Sipos, A, Breza, N, Szántai-Kis, C, Kékesi, L, Garamvölgyi, R, Nemes, Z, Neumann, L, Torka, R, Ullrich, A, Kéri, G, Orfi, L
Published in Current medicinal chemistry (01.06.2014)
Published in Current medicinal chemistry (01.06.2014)
Get more information
Journal Article
Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis
HEGYMEGI-BARAKONYI, B, SZEKELY, R, MESZAROS, G, MAROSFALVI, J, ERÖS, D, SZANTAI-KIS, C, BREZA, N, GARAVAGLIA, S, PEROZZI, S, RIZZI, M, HAFENBRADL, D, KO, M, VARGA, Z, AV-GAY, Y, KLEBL, B. M, ORFI, L, KERI, G, KISS, R, BORBELY, G, NEMETH, G, BANHEGYI, P, PATO, J, GREFF, Z, HORVATH, Z
Published in Current medicinal chemistry (01.11.2008)
Published in Current medicinal chemistry (01.11.2008)
Get full text
Journal Article
Prediction Oriented QSAR Modelling of EGFR Inhibition
Szántai-Kis, C, Kövesdi, I, Eros, D, Bánhegyi, P, Ullrich, A, Kéri, G, Orfi, L
Published in Current medicinal chemistry (01.02.2006)
Published in Current medicinal chemistry (01.02.2006)
Get full text
Journal Article
18P NEK1 is a novel cancer target driving tumor growth through altered immune signaling
Ruiz-Pérez, M.V., Gaspar, I., Fekete, I., Szántai-Kis, C., Connolly, S., Elek, B., Djurec, M., Hegedüs, C., Taisz, I., Veres, D.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article
A4.18 The effects of SRC-family kinase inhibitors on osteoclast development in vitro
Csete, D, Győri, D, Vántus, T, Kéri, G, Szántai-Kis, C, Mócsai, A
Published in Annals of the rheumatic diseases (01.03.2015)
Published in Annals of the rheumatic diseases (01.03.2015)
Get full text
Journal Article
A4.18The effects of SRC-family kinase inhibitors on osteoclast development in vitro
Csete, D, Gyori, D, Vantus, T, Keri, G, Szantai-Kis, C, Mocsai, A
Published in Annals of the rheumatic diseases (01.03.2015)
Published in Annals of the rheumatic diseases (01.03.2015)
Get full text
Journal Article
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology
Kéri, György, Székelyhidi, Zsolt, Bánhegyi, Péter, Varga, Zoltán, Hegymegi-Barakonyi, Bálint, Szántai-Kis, Csaba, Hafenbradl, Doris, Klebl, Bert, Muller, Gerhard, Ullrich, Axel, Erös, Dániel, Horváth, Zoltán, Greff, Zoltán, Marosfalvi, Jenö, Pató, János, Szabadkai, István, Szilágyi, Ildikó, Szegedi, Zsolt, Varga, István, Wáczek, Frigyes, Orfi, László
Published in Assay and drug development technologies (01.10.2005)
Published in Assay and drug development technologies (01.10.2005)
Get more information
Journal Article